STOCK TITAN

Renatus Tactical Acquisition Corp I 10-Q Filings

RTAC NASDAQ

Every 10-Q that Renatus Tactical Acquisition Corp I (RTAC) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow RTAC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RTAC filings page.

Rhea-AI Summary

Renatus Tactical Acquisition Corp I is a Cayman Islands special purpose acquisition company formed in 2024 to complete a business combination. It completed an IPO on May 16, 2025, selling 24,150,000 units at $10.00 each and a concurrent private placement of 3,821,591 warrants at $1.00, with total transaction costs of $12.2 million.

As of June 30, 2026, total assets were $252.7 million, almost all in a Trust Account holding $252.4 million in cash and U.S. government securities, backing 24,150,000 Class A shares subject to redemption at $10.45 per share. The company reported net income of $3.53 million for the six months ended June 30, 2026, driven by $4.20 million of interest income on trust assets and modest operating expenses.

Liquidity outside the trust is very limited: cash on hand was $477 with working capital of $179,443, and management disclosed that this will not fund operations for the next 12 months. The company has $630,000 of investor convertible notes outstanding and a deferred underwriting fee of $8.45 million. It must complete a business combination by May 16, 2027 or liquidate, and the filings state that these conditions raise substantial doubt about its ability to continue as a going concern.

Rhea-AI Summary

Renatus Tactical Acquisition Corp I reports net income of $1,808,560 for the quarter ended March 31, 2026, driven mainly by $2,091,474 of interest on its IPO trust assets, partly offset by $282,914 of formation and operating expenses.

Cash in the trust account reached $250,274,966, while cash outside the trust was only $10,977, leading management to highlight substantial doubt about the company’s ability to continue as a going concern without additional financing or a business combination.

The SPAC has 24,150,000 Class A ordinary shares subject to redemption and 7,011,288 Class B ordinary shares outstanding, has issued investor convertible notes totaling $330,000, and is still seeking a suitable target for its initial business combination.

Rhea-AI Summary

Renatus Tactical Acquisition Corp I (RTAC) is a Cayman Islands SPAC that completed its IPO on May 16, 2025, selling 24,150,000 units at $10.00 each and placing $242,103,750 into a trust account. As of September 30, 2025, cash held in the trust had grown to $245,856,825 from interest on U.S. government securities, generating non-operating income of $3,753,075 for the nine-month period.

For the nine months ended September 30, 2025, the company reported net income of $2,971,498, driven by trust interest and offset by $783,450 of formation and operating expenses. Outside the trust, RTAC held only $97,362 of cash and working capital of $601,011, and management states these resources are not sufficient to fund operations for the next twelve months, leading to substantial doubt about its ability to continue as a going concern.

RTAC has 24,150,000 Class A ordinary shares subject to redemption at $10.18 per share and 7,011,288 Class B founder shares outstanding. It also has 12,075,000 public warrants and 3,821,591 private placement warrants outstanding, plus a $250,000 zero-interest investor convertible note that can convert into units at $5.00 per unit upon completion of a business combination. The company has not yet identified or completed a business combination and expects to continue incurring costs as it searches for a target within its 24–30 month combination window.